Subscribe Now Subscribe Today
Research Article
 

Dyslipidemia Induced by Atenolol in Common Rabbits Oryctolagus cuniculus



Ruqaiya Hasan , Aisha Javaid and Tayyaba Abbasi
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

The study was conducted to find out the effects of atenolol on blood lipid profile of common rabbits (Oryctolagus cuniculus). The administration of an oral dose of 0.6 mg atenolol kg-1 day-1 for 27 days produced a strong dyslipidemia, which was evident by a significant (p<0.05) reduction in mean plasma cholesterol and triglycerides levels, a marked alteration in mean HDL-cholesterol concentration and a non-significant elevated level of LDL-cholesterol. These findings suggest that atenolol is an inappropriate antihypertensive monotherapic agent for patients suffering with the abnormalities of lipid metabolism.

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

Ruqaiya Hasan , Aisha Javaid and Tayyaba Abbasi , 2006. Dyslipidemia Induced by Atenolol in Common Rabbits Oryctolagus cuniculus . International Journal of Pharmacology, 2: 553-556.

DOI: 10.3923/ijp.2006.553.556

URL: https://scialert.net/abstract/?doi=ijp.2006.553.556

REFERENCES
Anonymous, 1997. The 6th report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Arch. Internal Med., 157: 2413-2446.
PubMed  |  Direct Link  |  

Benowitz, N.L., 1998. Antihypertensive Agents. In: Basic and Clinical Pharmacology, Katzung, B.G. (Ed.). Appleton and Lange, USA., pp: 150-152.

Black, H.R., W.J. Elliott and J.D. Neaton, 2001. Base line characteristics and elderly blood pressure control in the CONVINCE trial. Hypertension, 37: 12-18.
Direct Link  |  

Cushman, W.C., C.E. Ford and J.A. Cutler, 2002. Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid lowering treatment to prevent heart attack trail (ALLHAT). J. Clin. Hypertens. (Greenwich), 4: 393-404.
Direct Link  |  

Fogari, R., A. Zoppi, L. Corradi, P. Preti, A. Mugellini and P. Lusardi, 1999. Beta blocker effects on the plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia. J. Cardiovasc. Pharmacol., 33: 534-539.
Direct Link  |  

Grossman, E. and F.H. Messerli, 2002. Why beta-blockers are not cardio protective in elderly patients with hypertension. Curr. Cardiol. Rep., 4: 468-473.
Direct Link  |  

Guyton, A.C. and J.E. Hall, 2000. Heart Muscle, the Heart as a Pump: The Autonomic Nervous System and the Adrenal Medulla. In: Textbook of Medical Physiology, Guyton, A.C. and J.E. Hall (Eds.). W.B. Saunders Co., Philadelphia, USA., pp: 105, 707.

Kuster, G.M., F.W. Amann, C. Neuenschwander and H. Drexel, 2002. High density lipoprotein sub fraction of patients using cardio selective beta-blockers. J. Cardiovasc. Drugs Ther., 16: 127-131.
Direct Link  |  

Lewington, S., R. Clarke, N. Qizilbash, R. Peto and R. Collins, 2002. Age-specific relevance of usual blood pressure to vascular mortality. Lancet, 360: 1903-1913.
Direct Link  |  

Mycek, M.J., R.A. Harvey and P.C. Champe, 2000. Adrenergic Antagonists. In: Lipincott`s Illustrated Reviews, Pharmacology, Harvey, R.A. and P.C. Champe (Eds.). Lipincott Williams and Wilkins, Philadelphia, pp: 73.

Mycek, M.J., R.A. Harvey and P.C. Champe, 2000. Antihypertensive Drugs. In: Lipincotts Illustrated Reviews, Pharmacology, Harvey, R.A. and P.C. Champe (Eds.). Lipincott Williams and Wilkins, Philadelphia, pp: 179-185.

Neal, B., S. MacMohan and N. Chapman, 2000. Effects of ACE inhibitors, calcium antagonists and other blood pressure-lowering drugs. Lancet, 356: 1955-1964.
Direct Link  |  

Rabkins, S.W., M.W. Huff, C. Newman, D. Sim and S.G. Carruthers, 1994. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: The alpha beta Canada study. Hypertension, 24: 241-248.
Direct Link  |  

Reith, D.M., A.H. Dawson, D. Epid, I.M. Whyte, N.A. Buckley and G.P. Sayer, 1996. Relative toxicity of beta-blockers in overdose. J. Toxicol. Clin. Toxicol., 34: 273-278.
Direct Link  |  

Thulin, T., A. Lehtonen, C. Dahlof, P.E. Nilsson, L. Enqvist, C. Lagerstedt and E. Berglund, 1999. Long-term effects of diltiazem and atenolol on blood glucose, serum lipids and serum urate in hypertensive patients. J. Clin. Pharmacol. Ther., 37: 28-33.

Valimaki, M., L. Maass, K. Harno and E.A. Nikkila, 1986. Lipoprotein lipids and apoproteins during β-blocker administration: Comparison of penbutolol and atenolol. Eur. J. Clin. Pharmacol., 30: 17-20.
Direct Link  |  

Wilhelmsen, L., M. Koster, P. Harmsen and G. Lappas, 2005. Differences between coronary disease and stroke in incidence, case fatality and risk factors, but few differences in risk factors for fatal and non-fatal events. Eur. Heart J., 26: 1916-1922.
Direct Link  |  

Yang, H. and A. Fayad, 2003. Are β-blockers anesthetics?. Can. J. Anesthesia, 50: 627-630.
Direct Link  |  

©  2020 Science Alert. All Rights Reserved